查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413067

多重检测免疫检测市场：按技术、分析类型、应用和最终用户划分 - 2024-2030 年全球预测

Multiplex Detection Immunoassays Market by Technique, Assay Type (Antibody Arrays, Bead-based assay, Blends Protein Arrays ), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

多重检测免疫检测分析市场规模预计2023年为21.1亿美元，2024年达22.5亿美元，预计2030年将达到33.7亿美元，复合年增长率为6.92%。

多重免疫检测的全球市场

主要市场统计
基准年[2023] 21.1亿美元
预测年份 [2024] 22.5亿美元
预测年份 [2030] 33.7亿美元
复合年增长率（%） 6.92%
多重检测免疫分析市场-IMG1

FPNV定位矩阵

FPNV 定位矩阵对于评估多重侦测免疫检测市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对多重检测免疫检测市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-多重检测免疫检测分析市场的市场规模与预测是多少？

2-在多重免疫检测市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-多重免疫检测市场的技术趋势和法律规范是什么？

4-多重检测免疫检测市场主要供应商的市场占有率为何？

5-进入多重检测免疫检测市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地慢性病和感染疾病的发生率正在上升
      • 对个体化精准医疗的兴趣日益浓厚
      • 政府对药物开发和研究活动提供优惠资助
    • 抑制因素
      • 相关的设备复杂性和高成本
    • 机会
      • 医疗保健和製药业先进技术的出现
      • 临床诊断自动化设备快速发展
    • 任务
      • 缺乏熟练且经验丰富的主题专家
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章多重检测免疫检测市场：依技术分类

  • 基于生物感测器的技术
  • 基于核酸的技术
  • 基于蛋白质的技术

第七章依检测类型分類的多重检测免疫检测市场

  • 抗体阵列
  • 基于微珠的检测
  • 蛋白质阵列混合（多重 ELISA）
  • 磁珠底座
  • 非磁珠底座
  • 平面分析

第八章多重检测免疫检测市场：依应用

  • 疾病检测
  • 食品污染检验
  • 研究与开发
  • 兽医疾病检测

第九章多重检测免疫检测市场：依最终用户分类

  • 学术研究所
  • 生技公司
  • 临床研究组织
  • 诊断中心
  • 食品和饮料公司
  • 製药公司

第十章美洲多重免疫检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太多重免疫检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲多重免疫检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：按主要企业划分
  • 主要企业竞争情境分析

第14章竞争产品组合

  • 主要公司简介
    • Abcam PLC
    • Advanced Cell Diagnostics, Inc.
    • Aehealth Limited
    • Assay Genie
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Charles River Laboratories
    • Elabscience Biotechnology Inc.
    • Fortis Life Sciences LLC
    • Illumina Inc.
    • Luminex Corporation by DiaSorin SpA
    • Merck KGaA
    • Meso Scale Diagnostics, LLC
    • PerkinElmer Inc.
    • Promega Corporation
    • Qiagen NV
    • Quansys Biosciences Inc.
    • Quanterix Corporation
    • R&D Systems, Inc.
    • Randox Laboratories Ltd.
    • Sartorius AG
    • Scienion by Bico Company
    • Scorpius BioManufacturing
    • Seegene Inc.
    • Thermo Fisher Scientific Inc.
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-FF012EDC38DC

[198 Pages Report] The Multiplex Detection Immunoassays Market size was estimated at USD 2.11 billion in 2023 and expected to reach USD 2.25 billion in 2024, at a CAGR 6.92% to reach USD 3.37 billion by 2030.

Global Multiplex Detection Immunoassays Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.11 billion
Estimated Year [2024] USD 2.25 billion
Forecast Year [2030] USD 3.37 billion
CAGR (%) 6.92%
Multiplex Detection Immunoassays Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Multiplex Detection Immunoassays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Multiplex Detection Immunoassays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Multiplex Detection Immunoassays Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Advanced Cell Diagnostics, Inc., Aehealth Limited, Assay Genie, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Charles River Laboratories, Elabscience Biotechnology Inc., Fortis Life Sciences LLC, Illumina Inc., Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Meso Scale Diagnostics, LLC, PerkinElmer Inc., Promega Corporation, Qiagen N.V., Quansys Biosciences Inc., Quanterix Corporation, R&D Systems, Inc., Randox Laboratories Ltd., Sartorius AG, Scienion by Bico Company, Scorpius BioManufacturing, Seegene Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiplex Detection Immunoassays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technique
    • Biosensor-Based Techniques
    • Nucleic Acid-Based Techniques
    • Protein-Based Techniques
  • Assay Type
    • Antibody Arrays
    • Bead-based assay
    • Blends Protein Arrays (Multiplexed ELISA)
    • Magnetic Bead-based
    • Non-magnetic Bead-based
    • Planar Assay
  • Application
    • Disease Testing
    • Food Contamination Testing
    • Research and Development
    • Veterinary Disease Testing
  • End-User
    • Academic Research Institutes
    • Biotechnology Companies
    • Clinical Research Organizations
    • Diagnostic Centers
    • Food & Beverages Companies
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Multiplex Detection Immunoassays Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Multiplex Detection Immunoassays Market?

3. What are the technology trends and regulatory frameworks in the Multiplex Detection Immunoassays Market?

4. What is the market share of the leading vendors in the Multiplex Detection Immunoassays Market?

5. Which modes and strategic moves are suitable for entering the Multiplex Detection Immunoassays Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Multiplex Detection Immunoassays Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of chronic and infectious diseases across the globe
      • 5.1.1.2. Growing preference for personalized -precision medicines
      • 5.1.1.3. Favorable government funding for drug development and research activities
    • 5.1.2. Restraints
      • 5.1.2.1. Associated complexity and high cost of equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of advanced technologies in the healthcare and pharmaceutical industry
      • 5.1.3.2. Rapid development of automated instruments in clinical diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled and experienced subject matter experts
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Multiplex Detection Immunoassays Market, by Technique

  • 6.1. Introduction
  • 6.2. Biosensor-Based Techniques
  • 6.3. Nucleic Acid-Based Techniques
  • 6.4. Protein-Based Techniques

7. Multiplex Detection Immunoassays Market, by Assay Type

  • 7.1. Introduction
  • 7.2. Antibody Arrays
  • 7.3. Bead-based assay
  • 7.4. Blends Protein Arrays (Multiplexed ELISA)
  • 7.5. Magnetic Bead-based
  • 7.6. Non-magnetic Bead-based
  • 7.7. Planar Assay

8. Multiplex Detection Immunoassays Market, by Application

  • 8.1. Introduction
  • 8.2. Disease Testing
  • 8.3. Food Contamination Testing
  • 8.4. Research and Development
  • 8.5. Veterinary Disease Testing

9. Multiplex Detection Immunoassays Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. Biotechnology Companies
  • 9.4. Clinical Research Organizations
  • 9.5. Diagnostic Centers
  • 9.6. Food & Beverages Companies
  • 9.7. Pharmaceutical Companies

10. Americas Multiplex Detection Immunoassays Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Multiplex Detection Immunoassays Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Multiplex Detection Immunoassays Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abcam PLC
    • 14.1.2. Advanced Cell Diagnostics, Inc.
    • 14.1.3. Aehealth Limited
    • 14.1.4. Assay Genie
    • 14.1.5. Becton, Dickinson and Company
    • 14.1.6. Bio-Rad Laboratories, Inc.
    • 14.1.7. Charles River Laboratories
    • 14.1.8. Elabscience Biotechnology Inc.
    • 14.1.9. Fortis Life Sciences LLC
    • 14.1.10. Illumina Inc.
    • 14.1.11. Luminex Corporation by DiaSorin S.p.A.
    • 14.1.12. Merck KGaA
    • 14.1.13. Meso Scale Diagnostics, LLC
    • 14.1.14. PerkinElmer Inc.
    • 14.1.15. Promega Corporation
    • 14.1.16. Qiagen N.V.
    • 14.1.17. Quansys Biosciences Inc.
    • 14.1.18. Quanterix Corporation
    • 14.1.19. R&D Systems, Inc.
    • 14.1.20. Randox Laboratories Ltd.
    • 14.1.21. Sartorius AG
    • 14.1.22. Scienion by Bico Company
    • 14.1.23. Scorpius BioManufacturing
    • 14.1.24. Seegene Inc.
    • 14.1.25. Thermo Fisher Scientific Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. MULTIPLEX DETECTION IMMUNOASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. MULTIPLEX DETECTION IMMUNOASSAYS MARKET DYNAMICS
  • FIGURE 7. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 8. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. MULTIPLEX DETECTION IMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 6. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BIOSENSOR-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY NUCLEIC ACID-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PROTEIN-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ANTIBODY ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BEAD-BASED ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BLENDS PROTEIN ARRAYS (MULTIPLEXED ELISA), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY MAGNETIC BEAD-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY NON-MAGNETIC BEAD-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PLANAR ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY FOOD CONTAMINATION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY VETERINARY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY FOOD & BEVERAGES COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. MULTIPLEX DETECTION IMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 197. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. MULTIPLEX DETECTION IMMUNOASSAYS MARKET LICENSE & PRICING